Dr. Marschall S. Runge
MD, PhD · Cardiologist · Author

Marschall S. Runge

Cardiologist, molecular biologist, and former CEO of Michigan Medicine. Forty years of cardiovascular and longevity research, written and spoken for readers outside the lab.

"Medicine is not just a science and an art; it is also a business. It's about adapting—and fast. Those who aren't paying attention will be left behind." The Great Healthcare Disruption, p. 2

Onstage and on air

Recent talks and broadcasts on the future of American medicine.

UCLA Paul Torrens Health Forum: Dr. Runge in panel discussion UCLA · Torrens Forum 10:00 in

UCLA Paul Torrens Health Forum

Panel discussion at UCLA's Paul Torrens Health Forum: "Disruption: The Reshaping of American Healthcare."

Instagram · Reel

UofM Alumni Association, Chicago

Fall presentation to the UM Alumni Association of Chicago.

Facebook · Reel

Healthcare Disruption: highlight reel

Short-form clip from the Great Healthcare Disruption book launch.

Marschall S. Runge

MD, PhD · Cardiologist · Researcher
Former Dean & CEO, Michigan Medicine

Forty years in cardiovascular medicine and longevity research

Dr. Marschall Runge is a cardiologist and molecular biologist whose research helped establish the role of oxidative stress and mitochondrial dysfunction in cardiovascular aging. As executive vice president for medical affairs at the University of Michigan, dean of the medical school, and CEO of Michigan Medicine, he led the system through a decade of expansion in digital health, precision medicine, and aging research.

He earned his PhD in cardiovascular molecular biology at Vanderbilt and his MD at Johns Hopkins, where he also completed his residency in internal medicine. He was a cardiology fellow at Massachusetts General Hospital.

His PubMed record runs to nearly 200 peer-reviewed papers and five patents. The early work identified NADPH oxidase (NOX4)-derived superoxide and mitochondrial DNA damage as primary drivers of atherosclerosis and vascular aging; the later work on Plasminogen Activator Inhibitor-1 (PAI-1) connected those mechanisms to fibrosis and hypertension. He now leads a multi-omic longevity initiative at Michigan that links epigenetic aging clocks, mitochondrial-nuclear crosstalk, and chronic inflammation, and writes for general readers on the same questions.

Books by Dr. Runge

Cover of The Great Healthcare Disruption by Dr. Marschall S. Runge (Forbes Books, 2025)
Nonfiction · Healthcare · Technology · Policy

The Great Healthcare Disruption

Big Tech, Bold Policy, and the Future of American Medicine

Published: Forbes Books, 2025

Healthcare change isn't coming. It's here. Drawing on four decades as a clinician, researcher, and CEO of Michigan Medicine, Dr. Runge looks at what AI, Big Tech, retail medicine, and federal policy are actually doing to American medical care, and what they aren't.

Key Topics:

  • AI-driven diagnostics and personalized medicine
  • Retail medicine and direct-to-consumer healthcare models
  • Gene therapy and next-generation obesity medications
  • Digital health transformation and electronic health records
  • Policy frameworks for innovation and equity
  • The future of academic medicine and clinical research

Why read it: Written for patients, clinicians, and the people running healthcare organizations and policy. A clear-eyed account of where American medicine is headed and what to expect.

Cover of Coded to Kill by Dr. Marschall S. Runge (Post Hill Press, 2023)
Fiction · Techno-Medical Thriller · Suspense

Coded to Kill

A Techno-Medical Thriller

Published: Post Hill Press, 2023

After a decade of development, Drexel Hospital's new Electronic Health Records system is about to become the national standard, housing the real-time medical records of every American. A former NSA operative sees the system as a tool for unimaginable power. Only a loose-knit group of hospital employees with conflicting loyalties can stop him.

Why this book matters: A medical thriller written by someone who has actually run hospitals. The questions it raises are no longer hypothetical: Who owns your medical record? What happens when the system designed to save your life becomes the weapon?

Perfect for: Fans of Robin Cook and Michael Crichton, and anyone uneasy about who has access to their medical records.

What's Coming Next

In development: a third nonfiction book, a Substack on epigenetics and biological aging, an open-enrollment Michigan course, and a multi-PI longevity research initiative.

In Development · Nonfiction

The Negotiation of a Lifetime

Agented by Thomas LeBien · Forbes Books · Heather Wagner, editorial

A general-audience book on epigenetic clocks, the science of biological age, and how to use that measurement to negotiate with your own genes. The premise: aging may not be one-way.

"The question isn't just how long we want to live but how well. In the quest for immortality, perhaps the greatest wisdom is recognizing that a meaningful, healthy life may be the best legacy of all." The Great Healthcare Disruption, p. 164

Pitching publishers · Spring 2026

Forthcoming · Newsletter

The Longevity Switch on Substack

Weekly notes on turning on your best genes

A regular dispatch separating biology from influencer hype. What daily choices actually do, through epigenetic regulation, to shift biological age.

Launching 2026 · Notify me at launch →

Forthcoming · Online Course

The Longevity Switch MOOC

University of Michigan Center for Academic Innovation

An approved massive open online course (MOOC) through UM's Center for Academic Innovation on epigenetics, maternal mtDNA inheritance, and aging. Three cohorts per year planned.

UM Center for Academic Innovation · Notify me at launch →

Active · Translational Research

Living Longer, Living Better

Cardiorespiratory fitness, methylation arrays, and maternal mtDNA inheritance, all in one cohort

A multi-PI initiative with Steven Kunkel, Brian Athey, and Sachin Kheterpal at Michigan, building a "Longevity & Cardiovascular Health Index" from DoDSR/USAFSAM/Cooper/VETS biospecimen archives.

View the methodology →

Where I Speak, Write, and Advise

Five subjects Dr. Runge speaks and writes on, each rooted in clinical or laboratory work and feeding into forthcoming projects: the Longevity Switch Substack, a Michigan MOOC on epigenetics and aging, and a third nonfiction book with Forbes Books.

🧬

Longevity & Healthy Aging

Mitochondrial dysfunction, epigenetic clocks, and the parts of healthspan you can actually move. Lead investigator on a multi-omic Michigan initiative linking cardiorespiratory fitness, methylation arrays, and maternal mtDNA inheritance.

"Aging is now understood as a complex biological process with multiple interconnected mechanisms. Under the new paradigm, what's been done might be undone." The Great Healthcare Disruption, p. 170
💊

Obesity Medication & GLP‑1s

What a generation of GLP-1 weight-loss drugs is changing in primary care, endocrinology, and cardiometabolic risk, and what patients should and shouldn't expect from them.

🧠

AI in Medicine

Where AI is actually changing care delivery (diagnostic decision support, ambient documentation, algorithmic triage), where the hype runs ahead of the evidence, and what to ask before trusting any of it.

🏥

The Future of American Healthcare

Big Tech in care delivery, retail medicine, the restructuring of payers, and the policy choices that will decide who benefits. The thesis of The Great Healthcare Disruption.

🔍

Who to Trust With Your Health

Separating credible expertise from the influencer industrial complex. How to evaluate longevity claims and find guidance you can actually use, in an era saturated with biological reductionism dressed up as science.

Upcoming Talks & Events

Interested in booking Dr. Runge for your next event?

Request a Speaking Engagement

Current Research & Publications

195+
Peer-Reviewed Publications
PubMed →
5
Healthcare Patents
40+
Years of Cardiovascular Research
Mitochondrial dysfunction driving inflammaging (schematic)
🧬

Living Longer, Living Better: Epigenetic Aging & Inflammaging

An initiative investigating how mitochondrial dysfunction and epigenetic modifications drive the "vicious cycle" of inflammaging and age-related disease. The project links cardiorespiratory fitness phenotypes to multi-omic epigenetic biomarkers, with the goal of building a "Longevity & Cardiovascular Health Index."

Scientific focus: ROS-induced mtDNA damage → DAMP release → cGAS-STING activation → chronic inflammation → cellular senescence. Reading the same axis in fitness phenotypes, methylation arrays, and mtDNA inheritance is the bet behind the longevity index.

Research Leaders: Steven Kunkel, PhD (UM), Brian Athey, PhD (UM), Sachin Kheterpal, MD, MBA (UM), Marschall Runge, MD, PhD (UM)

Translational Research Epigenetics Longevity
Telomere maintenance mechanisms (schematic)
🔬

Telomere Maintenance Mechanisms in Cancer & Aging

Long-read telomere sequencing for Telomere Maintenance Mechanism (TMM) profiling in liposarcoma. The platform combines Telo-seq on Oxford Nanopore, PacBio HiFi, Cas9-targeted enrichment, and SMA-seq reference standards to resolve Alternative Lengthening of Telomeres (ALT), arm-specific dynamics, and native subtelomeric methylation.

Key insight: Long-read sequencing reads native 5mC/5hmC marks, so aging signatures map directly onto the telomeric sequence, putting cancer biology and aging biology in one dataset.

Collaborators: Brian D. Athey, PhD (UM), Dennis Kappei, PhD (CSI Singapore), Rogel Cancer Center (UM)

Cancer Genomics Long-Read Sequencing Aging & Oncology
NOX4-derived ROS and atherogenesis (schematic)
🧓

NADPH Oxidase, Oxidative Stress & Cardiovascular Aging

Key finding: Reactive oxygen species (ROS) damage mtDNA, and that damage tracks with atherosclerosis progression. The work established mitochondria as an independent genetic contributor to vascular health, not just an energy-supply organelle.

Mechanism: NOX4-derived superoxide → mtDNA damage → metabolic reprogramming of macrophages → inflammatory response. The chain links oxidative metabolism to immune activation, and points to therapeutic targets in cardiovascular aging.

Frontiers in Immunology Antioxidants & Redox Signaling Vascular Biology
Vascular fibrosis and PAI-1 in hypertension (cardiac tissue)
❤️

Vascular Fibrosis, PAI-1 & Hypertension

Key finding: NIA-funded work on Plasminogen Activator Inhibitor-1 (PAI-1) and its role in vascular aging, fibrosis, and hypertension. The papers worked out the molecular mechanism behind plaque formation and vascular remodeling.

Mechanism: PAI-1 overexpression → impaired fibrinolysis → extracellular matrix accumulation → vascular fibrosis. PAI-1 sits at the intersection of cellular stress, mitochondrial dysfunction, and vascular aging, which is part of why age is the dominant risk factor for cardiovascular disease.

Hypertension (AHA) Circulation Research Aging & Fibrosis

Praise for The Great Healthcare Disruption

Editorial reviews from physicians, public-health figures, and healthcare leaders, taken from the book's Amazon listing.

★★★★★
"In the United States, we have some of the world's most advanced medical technology, highly specialized care, and world-class emergency services. At the same time, the system is inefficient, inequitable, and unsatisfying to nearly everyone who interacts with it. My friend Marschall Runge offers a compelling prescription for disruption. With four decades of experience — much of it at the very top of academic medicine — his insights are not only well-informed but well worth our attention."
Sanjay Gupta, MD
Chief Medical Correspondent, CNN; Associate Professor of Neurosurgery, Emory University School of Medicine; bestselling author and host of Chasing Life
★★★★★
"Dr. Marschall Runge delivers a bold and visionary roadmap for transforming American healthcare. With clarity and conviction, he explores how emerging technologies can revolutionize care — making it more affordable, equitable, and effective for all. But this is more than a call for innovation — it is a call for accountability. Dr. Runge challenges us to ask who truly benefits from progress, who is being left behind, and what courageous leadership must look like in this era of unprecedented disruption."
Victor J. Dzau, MD
President, National Academy of Medicine; Chancellor Emeritus, Duke University Health System
★★★★★
"In a pivotal era marked by entrepreneurship, innovation, and significant change in healthcare, Dr. Marschall Runge, a physician and healthcare leader, stands out as a seasoned voice in American medicine, speaking with both candor and courage. The Great Healthcare Disruption serves as a masterclass in leadership, exposing the systemic failures of our healthcare system, while presenting pragmatic solutions for reinvention. This book is not merely an academic text; it's a comprehensive blueprint for the bold transformation our nation urgently needs."
Michael M.E. Johns, MD
EVP for Health Affairs Emeritus, Emory University; Founding CEO Emory Healthcare; Former Dean, Johns Hopkins School of Medicine
★★★★★
"The American healthcare landscape is undergoing drastic changes, some of which are necessary, while others are problematic. Dr. Marschall Runge, who has led one of the leading US health systems and medical schools, is in a perfect position — and comes through — with an exceptionally thoughtful and thorough analysis, along with proposing solutions and policy changes."
Eric Topol, MD
Professor and EVP, Scripps Research; Founder and Director, SRTI
★★★★★
"In The Great Healthcare Disruption, Dr. Marschall Runge provides both a compelling case and detailed plan for the reimagination of healthcare. He is as practical as he is inspirational, calling upon leaders to follow a roadmap designed to make care more customer focused — easy to access, affordable, and rooted in prevention. As a fellow healthcare leader who also believes in the urgent need for industry transformation, I deeply appreciate Dr. Runge's bold vision and dedication to fixing what is broken."
Pete McCanna
CEO, Baylor Scott & White Health
★★★★★
"Health care is arguably moving faster than at any time since the era of vaccines and antibiotics a century ago. Runge hits the most important disruptors — AI, retail medicine, GLP‑1 agonists, personalized therapies — with the rigor and relatability uniquely brought by a physician and scientific leader. In addition to insightful reviews of each, he lays out how these innovations relate to and accelerate one another. While acknowledging the potential risks, Runge presents a compelling vision by which we move past the stagnant, expensive, and often underperforming health care system of today."
John Birkmeyer, MD
President, Sound Physicians; Professor (adjunct), Dartmouth Institute for Health Policy and Clinical Practice
★★★★★
"The Great Healthcare Disruption is a must-read for all who are passionate about improving healthcare and health outcomes in a financially sustainable way. Dr. Runge provides practical perspectives as an experienced clinician and prominent executive on one of the most important challenges facing the United States. He highlights the ethical and financial dilemmas for access to care and breakthrough therapies and drugs. Dr. Runge offers a future-forward roadmap and thought-provoking prescriptions for improving health outcomes while reducing healthcare costs."
Mark Hussey
CEO and President, Huron Consulting
★★★★★
"I loved the fact that the book summarizes Dr. Runge's assertions with 'The Takeaway', which provided a time to reflect… [I] hope and pray we can realize the need to collectively focus our resources on the many topics that Dr. Runge raised — merging mental health with primary care; using AI to address scarcity and access issues; and a focus on genetic medicine. Seemingly obvious, but not yet tackled in our healthcare delivery system."
Stephanie L. Reel
Former CIO, Johns Hopkins Medicine, Johns Hopkins Health System, and Johns Hopkins University

The Great Healthcare Disruption

Available in hardcover, Kindle, and audiobook.